GLYXAMBI® Empagliflozin / Linagliptin 10 mg - 5 mg Tablet 30 Tablets

Name: Antidiabetic Agent
Brand: GLYXAMBI®

GLYXAMBI, TAB 10MG/5MG (30/BT)

McKesson #

1233685

Manufacturer #

00597018230

Brand

GLYXAMBI®

Manufacturer

Boehringer Ingelheim

Country of Origin

Unknown

Alternate Manufacturer Number

3425006

Application

Antidiabetic Agent

Container Type

Bottle

Dosage Form

Tablet

Generic Drug Code

37832

Generic Drug Name

Empagliflozin / Linagliptin

NDC Number

00597018230

Product Dating

McKesson Acceptable Dating: we will ship >= 90 days

Quantity

30 Tablets

Strength

10 mg - 5 mg

UNSPSC Code

51181500

GLYXAMBI is a combination of empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor and linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease